Skip to main content
Top
Published in: Lung 1/2020

01-02-2020 | Bronchial Asthma | COPD

Are the Effects of High-Intensity Exercise Training Different in Patients with COPD Versus COPD+Asthma Overlap?

Authors: Antenor Rodrigues, Joice Mara de Oliveira, Karina Couto Furlanetto, Felipe Vilaça Cavallari Machado, Letícia Fernandes Belo, Lorena Paltanin Schneider, Andrea Akemi Morita, Ana Carolina Andrelo, Jéssica Fonseca, Igor Lopes Brito, Thaís Paes, Josiane Marques Felcar, Vanessa Suziane Probst, Nidia Aparecida Hernandes, Fabio Pitta

Published in: Lung | Issue 1/2020

Login to get access

Abstract

Purpose

This study aimed to investigate whether patients with chronic obstructive pulmonary disease (COPD) presenting asthma overlap (ACO) benefit similarly in comparison to patients with only COPD after a 12-week high-intensity exercise training (ET) program.

Methods

Subjects with a diagnosis of COPD alone or ACO were evaluated and compared before and after a high-intensity ET program composed of walking and cycling plus strengthening exercises of the upper and lower limbs (3 days/week, 3 months, 36 sessions). Assessments included spirometry, bioelectrical impedance, 6-min walk test (6MWT), London Chest Activity of Daily Living Scale (LCADL), Hospital anxiety and depression Scale, modified Medical Research Council Scale (mMRC), Saint George Respiratory Questionnaire (SGRQ), and respiratory and peripheral muscle strength [manovacuometry and 1-repetition maximum test (quadriceps femoris, biceps and triceps brachialis), respectively]. ACO was defined according to Sin et al. (Eur Respir J 48(3):664-673, 2016).

Results

The sample was composed of 74 subjects (57% male, age 67 ± 8 years, BMI 26 (21–32) kg/m2, FEV1 47 ± 17%predicted), and 12 (16%) of them were classified as presenting ACO. Both groups improved pulmonary function, 6MWT, peripheral and inspiratory muscle strength, LCADL, and SGRQ after ET (p < 0.005 for all). There were no significant interactions between ACO and COPD on ET effects (p > 0.05 for all). Likewise, there was no difference in the proportion of patients achieving the minimum clinical important difference for 6MWT and mMRC.

Conclusion

High-intensity exercise training generates similar benefits in patients with COPD regardless of whether presenting asthma overlap or not.
Literature
1.
go back to reference Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B et al (2006) American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 173(12):1390–1413CrossRef Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B et al (2006) American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 173(12):1390–1413CrossRef
2.
go back to reference Troosters T, Blondeel A, Janssens W, Demeyer H (2019) The past, present and future of pulmonary rehabilitation. Respirology 24(9):830–837CrossRef Troosters T, Blondeel A, Janssens W, Demeyer H (2019) The past, present and future of pulmonary rehabilitation. Respirology 24(9):830–837CrossRef
3.
go back to reference McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y (2015) Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2:CD003793 McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y (2015) Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2:CD003793
4.
go back to reference Lacasse Y, Cates CJ, McCarthy B, Welsh EJ (2015) This cochrane review is closed: deciding what constitutes enough research and where next for pulmonary rehabilitation in COPD. Cochrane Database Syst Rev 11:ED000107 Lacasse Y, Cates CJ, McCarthy B, Welsh EJ (2015) This cochrane review is closed: deciding what constitutes enough research and where next for pulmonary rehabilitation in COPD. Cochrane Database Syst Rev 11:ED000107
5.
go back to reference Spruit MA, Singh SJ, Garvey C, ZusWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD et al (2013) An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 188(8):e13–64CrossRef Spruit MA, Singh SJ, Garvey C, ZusWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD et al (2013) An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 188(8):e13–64CrossRef
6.
go back to reference Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF (1995) Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 152(4 Pt 1):1268–1274CrossRef Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF (1995) Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 152(4 Pt 1):1268–1274CrossRef
7.
go back to reference E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel, H.J. Zar (2008) Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31: 143–178. Eur Respir J 2018, 51(2). E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel, H.J. Zar (2008) Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31: 143–178. Eur Respir J 2018, 51(2).
8.
go back to reference Alshabanat A, Zafari Z, Albanyan O, Dairi M, FitzGerald JM (2015) Asthma and COPD overlap syndrome (ACOS): a systematic review and meta analysis. PLoS ONE 10(9):e0136065CrossRef Alshabanat A, Zafari Z, Albanyan O, Dairi M, FitzGerald JM (2015) Asthma and COPD overlap syndrome (ACOS): a systematic review and meta analysis. PLoS ONE 10(9):e0136065CrossRef
9.
go back to reference Tan WC, Bourbeau J, Aaron SD, Zhou G, Maltais F, Hernandez P, Fitzgerald JM, Marciniuk DD, Walker BL, Sin DD (2018) Global initiative for chronic obstructive lung disease 2017 classification and lung function decline in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 197(5):670–673CrossRef Tan WC, Bourbeau J, Aaron SD, Zhou G, Maltais F, Hernandez P, Fitzgerald JM, Marciniuk DD, Walker BL, Sin DD (2018) Global initiative for chronic obstructive lung disease 2017 classification and lung function decline in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 197(5):670–673CrossRef
10.
go back to reference Hanania NA, Celli BR, Donohue JF, Martin UJ (2011) Bronchodilator reversibility in COPD. Chest 140(4):1055–1063CrossRef Hanania NA, Celli BR, Donohue JF, Martin UJ (2011) Bronchodilator reversibility in COPD. Chest 140(4):1055–1063CrossRef
11.
go back to reference Sin DD, Miravitlles M, Mannino DM, Soriano JB, Price D, Celli BR, Leung JM, Nakano Y, Park HY, Wark PA et al (2016) What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J 48(3):664–673CrossRef Sin DD, Miravitlles M, Mannino DM, Soriano JB, Price D, Celli BR, Leung JM, Nakano Y, Park HY, Wark PA et al (2016) What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J 48(3):664–673CrossRef
12.
go back to reference Barnes PJ (2016) Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 138(1):16–27CrossRef Barnes PJ (2016) Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 138(1):16–27CrossRef
13.
go back to reference Leung JM, Sin DD (2017) Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets. BMJ 358:j3772CrossRef Leung JM, Sin DD (2017) Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets. BMJ 358:j3772CrossRef
14.
go back to reference Maselli DJ, Hardin M, Christenson SA, Hanania NA, Hersh CP, Adams SG, Anzueto A, Peters JI, Han MK, Martinez FJ (2019) Clinical approach to the therapy of asthma-COPD Overlap. Chest 155(1):168–177CrossRef Maselli DJ, Hardin M, Christenson SA, Hanania NA, Hersh CP, Adams SG, Anzueto A, Peters JI, Han MK, Martinez FJ (2019) Clinical approach to the therapy of asthma-COPD Overlap. Chest 155(1):168–177CrossRef
15.
go back to reference Cambach W, Chadwick-Straver RV, Wagenaar RC, van Keimpema AR, Kemper HC (1997) The effects of a community-based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial. Eur Respir J 10(1):104–113CrossRef Cambach W, Chadwick-Straver RV, Wagenaar RC, van Keimpema AR, Kemper HC (1997) The effects of a community-based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial. Eur Respir J 10(1):104–113CrossRef
16.
go back to reference Turner S, Eastwood P, Cook A, Jenkins S (2011) Improvements in symptoms and quality of life following exercise training in older adults with moderate/severe persistent asthma. Respiration 81(4):302–310CrossRef Turner S, Eastwood P, Cook A, Jenkins S (2011) Improvements in symptoms and quality of life following exercise training in older adults with moderate/severe persistent asthma. Respiration 81(4):302–310CrossRef
17.
go back to reference Foglio K, Bianchi L, Bruletti G, Battista L, Pagani M, Ambrosino N (1999) Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. Eur Respir J 13(1):125–132CrossRef Foglio K, Bianchi L, Bruletti G, Battista L, Pagani M, Ambrosino N (1999) Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. Eur Respir J 13(1):125–132CrossRef
18.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P et al (2005) Standardisation of spirometry. Eur Respir J 26(2):319–338CrossRef Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P et al (2005) Standardisation of spirometry. Eur Respir J 26(2):319–338CrossRef
19.
go back to reference Pereira CA, Sato T, Rodrigues SC (2007) New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 33(4):397–406CrossRef Pereira CA, Sato T, Rodrigues SC (2007) New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 33(4):397–406CrossRef
20.
go back to reference Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, McCormack MC, Carlin BW, Sciurba FC, Pitta F et al (2014) An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 44(6):1428–1446CrossRef Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, McCormack MC, Carlin BW, Sciurba FC, Pitta F et al (2014) An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 44(6):1428–1446CrossRef
21.
go back to reference Britto RR, Probst VS, de Andrade AF, Samora GA, Hernandes NA, Marinho PE, Karsten M, Pitta F, Parreira VF (2013) Reference equations for the six-minute walk distance based on a Brazilian Multicenter Study. Braz J Phys Ther 17(6):556–563CrossRef Britto RR, Probst VS, de Andrade AF, Samora GA, Hernandes NA, Marinho PE, Karsten M, Pitta F, Parreira VF (2013) Reference equations for the six-minute walk distance based on a Brazilian Multicenter Study. Braz J Phys Ther 17(6):556–563CrossRef
22.
go back to reference Kovelis D, Segretti NO, Probst VS, Lareau SC, Brunetto AF, Pitta F (2008) Validation of the modified pulmonary functional status and Dyspnea Questionnaire and the Medical Research Council Scale for use in Brazilian patients with chronic obstructive pulmonary disease. J Bras Pneumol 34(12):1008–1018CrossRef Kovelis D, Segretti NO, Probst VS, Lareau SC, Brunetto AF, Pitta F (2008) Validation of the modified pulmonary functional status and Dyspnea Questionnaire and the Medical Research Council Scale for use in Brazilian patients with chronic obstructive pulmonary disease. J Bras Pneumol 34(12):1008–1018CrossRef
23.
go back to reference Camelier A, Rosa FW, Salim C, Nascimento OA, Cardoso F, Jardim JR (2006) Using the Saint George's Respiratory Questionnaire to evaluate quality of life in patients with chronic obstructive pulmonary disease: validating a new version for use in Brazil. J Bras Pneumol 32(2):114–122CrossRef Camelier A, Rosa FW, Salim C, Nascimento OA, Cardoso F, Jardim JR (2006) Using the Saint George's Respiratory Questionnaire to evaluate quality of life in patients with chronic obstructive pulmonary disease: validating a new version for use in Brazil. J Bras Pneumol 32(2):114–122CrossRef
24.
go back to reference Kyle UG, Pichard C, Rochat T, Slosman DO, Fitting JW, Thiebaud D (1998) New bioelectrical impedance formula for patients with respiratory insufficiency: comparison to dual-energy X-ray absorptiometry. Eur Respir J 12(4):960–966CrossRef Kyle UG, Pichard C, Rochat T, Slosman DO, Fitting JW, Thiebaud D (1998) New bioelectrical impedance formula for patients with respiratory insufficiency: comparison to dual-energy X-ray absorptiometry. Eur Respir J 12(4):960–966CrossRef
25.
go back to reference Nyberg A, Saey D, Maltais F (2015) Why and how limb muscle mass and function should be measured in patients with chronic obstructive pulmonary disease. Ann Am Thorac Soc 12(9):1269–1277CrossRef Nyberg A, Saey D, Maltais F (2015) Why and how limb muscle mass and function should be measured in patients with chronic obstructive pulmonary disease. Ann Am Thorac Soc 12(9):1269–1277CrossRef
26.
go back to reference Black LF, Hyatt RE (1969) Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 99(5):696–702PubMed Black LF, Hyatt RE (1969) Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 99(5):696–702PubMed
27.
go back to reference Neder JA, Andreoni S, Lerario MC, Nery LE (1999) Reference values for lung function tests. II. Maximal respiratory pressures and voluntary ventilation. Braz J Med Biol Res 32(6):719–727CrossRef Neder JA, Andreoni S, Lerario MC, Nery LE (1999) Reference values for lung function tests. II. Maximal respiratory pressures and voluntary ventilation. Braz J Med Biol Res 32(6):719–727CrossRef
28.
go back to reference Rodrigues A, Di Martino M, Nellessen AG, Hernandes NA, Neder JA, Pitta F (2016) Is the six-minute walk test a useful tool to prescribe high-intensity exercise in patients with chronic obstructive pulmonary disease? Heart Lung 45(6):550–556CrossRef Rodrigues A, Di Martino M, Nellessen AG, Hernandes NA, Neder JA, Pitta F (2016) Is the six-minute walk test a useful tool to prescribe high-intensity exercise in patients with chronic obstructive pulmonary disease? Heart Lung 45(6):550–556CrossRef
29.
go back to reference Probst VS, Kovelis D, Hernandes NA, Camillo CA, Cavalheri V, Pitta F (2011) Effects of 2 exercise training programs on physical activity in daily life in patients with COPD. Respir Care 56(11):1799–1807CrossRef Probst VS, Kovelis D, Hernandes NA, Camillo CA, Cavalheri V, Pitta F (2011) Effects of 2 exercise training programs on physical activity in daily life in patients with COPD. Respir Care 56(11):1799–1807CrossRef
30.
go back to reference Pitta F, Troosters T, Probst VS, Langer D, Decramer M, Gosselink R (2008) Are patients with COPD more active after pulmonary rehabilitation? Chest 134(2):273–280CrossRef Pitta F, Troosters T, Probst VS, Langer D, Decramer M, Gosselink R (2008) Are patients with COPD more active after pulmonary rehabilitation? Chest 134(2):273–280CrossRef
31.
go back to reference de Torres JP, Pinto-Plata V, Ingenito E, Bagley P, Gray A, Berger R, Celli B (2002) Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest 121(4):1092–1098CrossRef de Torres JP, Pinto-Plata V, Ingenito E, Bagley P, Gray A, Berger R, Celli B (2002) Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest 121(4):1092–1098CrossRef
32.
go back to reference Vogiatzis I, Terzis G, Stratakos G, Cherouveim E, Athanasopoulos D, Spetsioti S, Nasis I, Manta P, Roussos C, Zakynthinos S (2011) Effect of pulmonary rehabilitation on peripheral muscle fiber remodeling in patients with COPD in GOLD stages II to IV. Chest 140(3):744–752CrossRef Vogiatzis I, Terzis G, Stratakos G, Cherouveim E, Athanasopoulos D, Spetsioti S, Nasis I, Manta P, Roussos C, Zakynthinos S (2011) Effect of pulmonary rehabilitation on peripheral muscle fiber remodeling in patients with COPD in GOLD stages II to IV. Chest 140(3):744–752CrossRef
33.
go back to reference Camillo CA, Langer D, Osadnik CR, Pancini L, Demeyer H, Burtin C, Gosselink R, Decramer M, Janssens W, Troosters T (2016) Survival after pulmonary rehabilitation in patients with COPD: impact of functional exercise capacity and its changes. Int J Chronic Obstr Pulm Dis 11:2671–2679CrossRef Camillo CA, Langer D, Osadnik CR, Pancini L, Demeyer H, Burtin C, Gosselink R, Decramer M, Janssens W, Troosters T (2016) Survival after pulmonary rehabilitation in patients with COPD: impact of functional exercise capacity and its changes. Int J Chronic Obstr Pulm Dis 11:2671–2679CrossRef
34.
go back to reference Dolmage TE, Goldstein RS (2008) Effects of one-legged exercise training of patients with COPD. Chest 133(2):370–376CrossRef Dolmage TE, Goldstein RS (2008) Effects of one-legged exercise training of patients with COPD. Chest 133(2):370–376CrossRef
35.
go back to reference Klijn P, van Keimpema A, Legemaat M, Gosselink R, van Stel H (2013) Nonlinear exercise training in advanced chronic obstructive pulmonary disease is superior to traditional exercise training. A randomized trial. Am J Respir Crit Care Med 188(2):193–200CrossRef Klijn P, van Keimpema A, Legemaat M, Gosselink R, van Stel H (2013) Nonlinear exercise training in advanced chronic obstructive pulmonary disease is superior to traditional exercise training. A randomized trial. Am J Respir Crit Care Med 188(2):193–200CrossRef
36.
go back to reference Sedgwick P (2015) Confidence intervals, P values, and statistical significance. BMJ 350:h1113CrossRef Sedgwick P (2015) Confidence intervals, P values, and statistical significance. BMJ 350:h1113CrossRef
37.
go back to reference Sullivan GM, Feinn R (2012) Using Effect Size-or why the P value is not enough. J Grad Med Educ 4(3):279–282CrossRef Sullivan GM, Feinn R (2012) Using Effect Size-or why the P value is not enough. J Grad Med Educ 4(3):279–282CrossRef
Metadata
Title
Are the Effects of High-Intensity Exercise Training Different in Patients with COPD Versus COPD+Asthma Overlap?
Authors
Antenor Rodrigues
Joice Mara de Oliveira
Karina Couto Furlanetto
Felipe Vilaça Cavallari Machado
Letícia Fernandes Belo
Lorena Paltanin Schneider
Andrea Akemi Morita
Ana Carolina Andrelo
Jéssica Fonseca
Igor Lopes Brito
Thaís Paes
Josiane Marques Felcar
Vanessa Suziane Probst
Nidia Aparecida Hernandes
Fabio Pitta
Publication date
01-02-2020
Publisher
Springer US
Published in
Lung / Issue 1/2020
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-019-00311-7

Other articles of this Issue 1/2020

Lung 1/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.